Showing 119 of 119on this page. Filters & sort apply to loaded results; URL updates for sharing.119 of 119 on this page
COMPASS Pathways Receives FDA Breakthrough Therapy Designation for ...
COMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) Given Consensus Rating ...
Board of Directors | Compass Pathways
Compass Pathways
CMPS | Обзор IPO COMPASS Pathways | Анализ IPO CMPS
Working at COMPASS Pathways | Glassdoor.co.uk
COMPASS Pathways Careers | Levels.fyi
COMPASS Pathways Announces Positive Results From Groundbreaking Phase ...
COMPASS Pathways announces pricing of upsized initial public offering
Compass Pathways establishes research collaboration with Mindful Health ...
Compass Pathways Establishes Strategic Collaboration with Radial to ...
Journey Clinical and Compass Pathways Announce Research Collaboration ...
COMPASS Pathways logo in transparent PNG and vectorized SVG formats
Taking a Look at Compass Pathways | A Synthetic Psilocybin Company ...
Compass Pathways at Kenneth Bray blog
Compass Pathways Psilocybin Therapy Hits 3.6-Point MADRS Endpoint; atai ...
About COMPASS Pathways | Our Values & Mental Health Innovations
COMPASS Pathways plc Stock — CMPS Overview — Roic AI
Compass Pathways CEO on mushroom-based therapy for depression: 'The ...
Compass Pathways launching NEW Phase II Clinical Trial to Treat PTSD ...
Compass Pathways to announce second quarter financial results on August ...
COMPASS Pathways Secures Term Loan Facility for Up to $50 Million from ...
Digital technologies | Compass Pathways
Compass Pathways | Biotechnology Company
Pipeline | Compass Pathways
COMPASS Pathways plc announces financial results and business ...
Compass Pathways Lost Its Co-Founders - Now What? | Psychedelic Invest
Compass Pathways PLC 8-K Report: Key Announcements for January 2025 ...
Compass Pathways Soars on Phase 3 Psilocybin Trial Success
Compass Pathways Wins FDA Green Light for PTSD Trial as Psilocybin ...
Our work | Compass Pathways
How Does COMPASS Pathways Company Work? – CanvasBusinessModel.com
Buy COMPASS Pathways Stock – CMPS Stock Quote Today & Investment ...
Compass Pathways Gains Credibility in CNS Biotech | Cannabis Risk Manager
Psychedelic: Exclusive talk with biotech company Compass Pathways ...
Compass Pathways Patents – Key Insights and Stats - Insights;Gate
About Compass Pathways | Our Values & Mental Health Innovations
Compass Pathways has just released topline results from the first-ever ...
Our publications and results | Compass Pathways
Compass Pathways (Nasdaq:CMPS) Enters Strategic Collaboration with ...
Compass Career Pathways | Kodiak College | Kodiak College
Compass Pathways To Start Phase II Trial For Psilocybin PTSD Therapy ...
Compass Pathways Pushes Back Phase 3 Readouts, Lays Off 30% of Staff ...
Pipeline overview | Compass Pathways
A Look at Compass Pathways and Clinical Results : psychedelicinvest
Compass Pathways Closes Enrollment For Phase IIb Psilocybin Clinical ...
COMP360 psilocybin treatment in TRD with antidepressants | Compass Pathways
Compass Pathways Accelerates COMP360 TRD Launch by 9–12 Months | CMPS ...
Lori Englebert | Compass Pathways
Compass Pathways Releases Promising New Data from Landmark Psilocybin ...
Is Compass Pathways Poised for Success? | Psychedelic Invest
Compass Pathways Plc (CMPS) | Finance information
Compass Pathways Sees "Reduction In Depressive Symptom" In Phase IIb ...
Psilocybin Discovery Center - Compass Pathways
Compass Pathways | Biotechnology Company | Compass Pathways
COMPASS Pathways - Tripsitter
COMPASS pathways brand generation - Projects - Like Sherbet
Compass Pathways set to become the first psychedelic biotech IPO | STAT
COMPASS Pathways (@COMPASSPathway) / Twitter
About psilocybin therapy | Compass Pathways
CMPS Insider Trading | COMPASS Pathways Buys and Sells
COMPASS Pathways plc - AnnualReports.com
Compass Pathways to Participate in Stifel 2025 Healthcare Conference ...
Compass Pathways - Activity, founders and funding with UnicornAlert
Compass Pathways – World Social Media Awards
COMPASS Pathways Talent Acquisition Specialist | Welcome to the Jungle ...
Compass Pathways enters into research collaboration agreement with ...
Min's internship story | Compass Pathways
Compass Pathways Achieves Breakthrough in Psilocybin Therapy for ...
COMPASS Pathways (CMPS) Stock Price & Overview
Compass Pathways Posts Q2 Earnings, Highlights Success and Challenges ...
Compass Pathways (NASDAQ:CMPS) Stock Price News
Compass Pathways (CMPS) Earnings Date and Reports 2026
Reality Check: Reflections on Compass Pathways' Phase IIb Topline Results
Compass Pathways’ Psilocybin Clears First Phase 3 Hurdle - Psychedelic ...
Veeva Compass | Patient Pathway | Veeva
Волшебные грибы от компании Compass Pathways.
Comprehensive Analysis of Compass Pathways: $CMPS | Psychedelic Vantage ...
La société biotechnologique Compass Pathways, axée sur les ...
Compass Pathways' Psilocybin Therapy Achieves Key Phase 3 Milestone ...
Compass Pathways' Opens Trading at $23.40 – Above Expected Range ...
COMPASS Pathways: Accelerating Patient Access To Evidence Based ...
Compass Pathways' Series B Pitch Deck Raised $80 Million for ...
Communicating Compass Pathways’ Purpose • GIG Health : GIG Health
The Top Companies Leading Psilocybin Research & Therapy
slide4
Best Biotech Stocks to Buy: A New Era of Medicine and a $100 Billion ...
Psychedelic Bulletin #120: Beckley Psytech Acquires Eleusis; A Look at ...
slide21
COMP360 Psilocybin for Treatment-Resistant Depression: Positive Phase 3 ...
Good Results for COMP360 Psilocybin in Bipolar Disorder Study | Microdose
compasspathways (COMPASS Pathways)
slide20
slide26
Portfolio
